128 related articles for article (PubMed ID: 23141385)
1. The economics of mild cognitive impairment.
Lin PJ; Neumann PJ
Alzheimers Dement; 2013 Jan; 9(1):58-62. PubMed ID: 23141385
[TBL] [Abstract][Full Text] [Related]
2. Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
Robinson RL; Rentz DM; Andrews JS; Zagar A; Kim Y; Bruemmer V; Schwartz RL; Ye W; Fillit HM
J Alzheimers Dis; 2020; 75(2):437-450. PubMed ID: 32250304
[TBL] [Abstract][Full Text] [Related]
3. The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in Ireland.
Gillespie P; O'Shea E; Cullinan J; Lacey L; Gallagher D; Ni Mhaolain A;
Int J Geriatr Psychiatry; 2013 Mar; 28(3):256-64. PubMed ID: 23386588
[TBL] [Abstract][Full Text] [Related]
4. [Using markov model to cost-effectiveness analysis of traditional Chinese medicine interference].
Wang N; Zhang ZJ; Chang D
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2698-701. PubMed ID: 23285912
[TBL] [Abstract][Full Text] [Related]
5. The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment.
Ton TGN; DeLeire T; May SG; Hou N; Tebeka MG; Chen E; Chodosh J
Alzheimers Dement; 2017 Mar; 13(3):217-224. PubMed ID: 27693186
[TBL] [Abstract][Full Text] [Related]
6. Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework.
Green C; Handels R; Gustavsson A; Wimo A; Winblad B; Sköldunger A; Jönsson L
Alzheimers Dement; 2019 Oct; 15(10):1309-1321. PubMed ID: 31402324
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.
Hernandez L; Ozen A; DosSantos R; Getsios D
Pharmacoeconomics; 2016 Jul; 34(7):681-707. PubMed ID: 26899832
[TBL] [Abstract][Full Text] [Related]
8. Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
Wimo A; Handels R; Winblad B; Black CM; Johansson G; Salomonsson S; Eriksdotter M; Khandker RK
J Alzheimers Dis; 2020; 75(3):891-902. PubMed ID: 32390617
[TBL] [Abstract][Full Text] [Related]
9. Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis.
Lin PJ; Zhong Y; Fillit HM; Chen E; Neumann PJ
J Am Geriatr Soc; 2016 Aug; 64(8):1549-57. PubMed ID: 27295430
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.
Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P
J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543
[TBL] [Abstract][Full Text] [Related]
11. Determinants of Medical Direct Costs of Care among Patients of a Memory Center.
Dauphinot V; Garnier-Crussard A; Moutet C; Delphin-Combe F; Späth HM; Krolak-Salmon P
J Prev Alzheimers Dis; 2021; 8(3):351-361. PubMed ID: 34101794
[TBL] [Abstract][Full Text] [Related]
12. Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer's disease: an interdisciplinary perspective.
Larouche E; Hudon C; Goulet S
Behav Brain Res; 2015 Jan; 276():199-212. PubMed ID: 24893317
[TBL] [Abstract][Full Text] [Related]
13. Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
Fukuda H; Kanzaki H; Murata F; Maeda M; Ikeda M
J Alzheimers Dis; 2023; 95(4):1559-1572. PubMed ID: 37718811
[TBL] [Abstract][Full Text] [Related]
14. The economics of Alzheimer disease.
Leung GM; Yeung RY; Chi I; Chu LW
Dement Geriatr Cogn Disord; 2003; 15(1):34-43. PubMed ID: 12457077
[TBL] [Abstract][Full Text] [Related]
15. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
16. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease.
Biasutti M; Dufour N; Ferroud C; Dab W; Temime L
PLoS One; 2012; 7(4):e35559. PubMed ID: 22532859
[TBL] [Abstract][Full Text] [Related]
18. 2009 Alzheimer's disease facts and figures.
Alzheimer's Association
Alzheimers Dement; 2009 May; 5(3):234-70. PubMed ID: 19426951
[TBL] [Abstract][Full Text] [Related]
19. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
20. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
